Orbital and rotational atherectomy during percutaneous coronary intervention for coronary artery calcification.
Michael S LeeJonathan S GordinGregg W StoneSamin K SharmaShigeru SaitoEhtisham MahmudJeff ChambersPhilippe GénéreuxRichard ShlofmitzPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
Severe coronary artery calcification (CAC) increases the complexity of percutaneous coronary intervention (PCI) by inhibiting optimal stent expansion, leading to an increased risk of death, myocardial infarction, repeat revascularization, and stent thrombosis. Coronary atherectomy modifies and debulks calcified plaque to facilitate PCI. Although there is no clear consensus, and further studies are needed, the decision to perform atherectomy should be based upon the presence of fluoroscopic CAC or with the use of intravascular imaging. The management of CAC in the modern era relies on rotational and orbital atherectomy to prepare the lesion to facilitate stent delivery and optimal expansion. While the two technologies differ in equipment, technique, and mechanism of action, the available literature suggests similar efficacy and safety of the two systems, although head-to-head comparisons are limited. While rotational and orbital atherectomy have been shown to have excellent procedural success in terms of facilitating stent delivery, no system has been shown to reduce long-term major adverse cardiovascular events, although the definitive trial for orbital atherectomy has not been completed. Additional trials are needed to find the population who would derive the most benefit of atherectomy and to compare the two systems in a prospective manner.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- coronary artery
- cardiovascular events
- st segment elevation myocardial infarction
- coronary artery bypass grafting
- acute myocardial infarction
- st elevation myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- pulmonary artery
- clinical trial
- atrial fibrillation
- chronic kidney disease
- systematic review
- heart failure
- left ventricular
- emergency department
- high resolution
- signaling pathway
- randomized controlled trial
- pulmonary arterial hypertension
- aortic valve
- phase iii
- mass spectrometry